World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
61
Citations
17071
World Ranking
3203
National Ranking
1500

Overview

John J. Donnelly is affiliated with Novartis in the United States. Their research spans primarily in the fields of Environmental Science and Medicine, with significant contributions to Ecology, Global and Planetary Change, Hematology, General Health Professions, and Nature and Landscape Conservation.

Donnelly's work covers a range of scientific topics, emphasizing Wildlife Ecology and Conservation, Fire Effects on Ecosystems, Avian Ecology and Behavior, Erythropoietin and Anemia Treatment, Rangeland and Wildlife Management, Iron Metabolism and Disorders, and Species Distribution and Climate Change.

The researcher has coauthored frequently with several others, including:

  • Paul R. Kalra
  • Daniel P. Collins
  • Mark C. Petrie
  • Iain Squire
  • Peter J. Cowburn

Donnelly has published across various venues, with repeated publications in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Ecosphere
  • Ecological Indicators
  • Ecology and Evolution
  • Journal of the American Medical Directors Association

Selected recent papers include:

  • "Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial," 2022, The Lancet
  • "Climate and human water use diminish wetland networks supporting continental waterbird migration," 2020, Global Change Biology
  • "Climate change and lithium mining influence flamingo abundance in the Lithium Triangle," 2022, Proceedings of the Royal Society B Biological Sciences
  • "Functional Wetland Loss Drives Emerging Risks to Waterbird Migration Networks," 2022, Frontiers in Ecology and Evolution
  • "Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial," 2024, European Heart Journal

Best Publications

  • Heterologous protection against influenza by injection of DNA encoding a viral protein

    Jeffrey B. Ulmer;John J. Donnelly;Suezanne E. Parker;Gary H. Rhodes

  • DNA VACCINES

    Unknown

  • DNA Vaccines: Progress and Challenges

    John J. Donnelly;Britta Wahren;Margaret A. Liu

  • Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus

    John J. Donnelly;Arthur Friedman;Douglas Martinez;Donna L. Montgomery

  • Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice.

    Marc Dupuis;Kimberly Denis-Mize;Carolyn Woo;Cheryl Goldbeck

  • Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes.

    T.-M. Fu;J. B. Ulmer;M. J. Caulfield;R. R. Deck

  • Heterologous and Homologous Protection Against Influenza A by DNA Vaccination: Optimization of DNA Vectors

    Donna L. Montgomery;John W. Shiver;Karen R. Leander;Helen C. Perry

  • Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells.

    J. B. Ulmer;R. R. Deck;C. M. Dewitt;J. J. Donnelly

  • PROTECTIVE CD4+ AND CD8+ T CELLS AGAINST INFLUENZA VIRUS INDUCED BY VACCINATION WITH NUCLEOPROTEIN DNA

    Jeffrey B. Ulmer;Tong-Ming Fu;R. Randall Deck;Arthur Friedman

  • Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines

    John Donnelly;Ducci O. Medini;Giusepp E. Boccadifuoco;Alessia Biolchi

  • Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment

    Ulrich Vogel;Muhamed-Kheir Taha;Julio A Vazquez;Jamie Findlow

  • Immunization of non-human primates with DNA vaccines

    Margaret A. Liu;William McClements;Jeffrey B. Ulmer;John Shiver

  • Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease.

    Carl E. Frasch;Ray Borrow;John Donnelly

  • Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines.

    Jeffrey M Ulmer;R.Randall Deck;Corrille M DeWitt;Arthur Friedman

  • Protection Against Papillomavirus with a Polynucleotide Vaccine

    J J Donnelly;D Martinez;K U Jansen;R W Ellis

  • Protection against Papillomavirus with a Polynucleotide Vaccine

    John J. Donnelly;Douglas Martinez;Kathrin U. Jansen;Ronald W. Ellis

  • Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation

    Kathrin U. Jansen;Mark Rosolowsky;Loren D. Schultz;Henry Z. Markus

  • Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans

    Davide Serruto;Tiziana Spadafina;Laura Ciucchi;Lisa A. Lewis

  • Technical and regulatory hurdles for DNA vaccines.

    John Donnelly;Karin Berry;Jeffrey B Ulmer

  • Enhancement of DNA vaccine potency in rhesus macaques by electroporation

    Gillis Otten;Mary Schaefer;Barbara Doe;Hong Liu

  • Purification, Characterization, and Immunogenicity of a Soluble Trimeric Envelope Protein Containing a Partial Deletion of the V2 Loop Derived from SF162, an R5-Tropic Human Immunodeficiency Virus Type 1 Isolate

    Indresh K. Srivastava;Leonidas Stamatatos;Elaine Kan;Michael Vajdy

  • Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells.

    K S Denis-Mize;M Dupuis;M Dupuis;M L MacKichan;M Singh

Frequent Co-Authors

Jeffrey B. Ulmer
Jeffrey B. Ulmer Novartis (Switzerland)
John W. Shiver
John W. Shiver United States Military Academy
Rino Rappuoli
Rino Rappuoli Imperial College London
Derek O'hagan
Derek O'hagan GlaxoSmithKline (United Kingdom)
Manmohan Singh
Manmohan Singh Beam Therapeutics
Nicholas M. Valiante
Nicholas M. Valiante Novartis (Switzerland)
Allen Oliff
Allen Oliff GlaxoSmithKline (United States)
Susan W. Barnett
Susan W. Barnett Bill & Melinda Gates Foundation
Margaret A. Liu
Margaret A. Liu Karolinska Institute
Marzia Monica Giuliani
Marzia Monica Giuliani GlaxoSmithKline (Italy)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare and research careers, often requiring advanced degrees and specialized training. For those interested in nursing-focused roles, exploring programs such as the cheapest online pmhnp certificate programs can be an affordable way to specialize in psychiatric nursing, which intersects with immunological health issues.

Nurses aiming to expand their scope or advance their careers might consider transitioning through pathways like the fnp to acute care np bridge program, which bridges family nurse practitioner skills with acute care, relevant for immuno-compromised patient care.

Accelerated tracks are also available for those seeking to enter the nursing workforce rapidly. The accelerated fnp programs provide an expedited path to becoming a family nurse practitioner, essential for frontline immunology-related healthcare.

Understanding potential earnings is crucial when planning your career. The dnp salary varies by location and specialization but generally offers strong financial incentives for advanced practice nurses engaged in immunology and related fields.

Best Scientists Citing John J. Donnelly

Trending Scientists